One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Category:Laboratory > Laboratory Consumable > Medium Product Name:HIPP-T009 serum-free medium for lymphocytes CAS No.:N/A Price(USD):Negotiable Company:Shanghai BioEngine Sci-Tech Co., Ltd.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Completely serum-free media specially designed to promote the in vitro culture of lymphocytes
The founding team of BioEngine started the study of in vitro culture of lymphocytes in the 1990s and had made great scientific achievements in this area. For prospective clinical application, the R&D team of BioEngine initiated the design and development of serum-free media for culturing of lymphocytes in vitro in 2015, and successfully obtained a completely serum-free medium formulation in 2018 which was launched with the name of HIPP-T009 in the same year. In 2020, HIPP-T009 became the first homegrown culture medium product used in cell therapy clinical trials in China.
HIPP-T009 is an ideal choice for large-scale culture of lymphocytes. It demonstrates not only excellent performance on cell expansion and functional expression but also ensures high safety and stability of the culture process since no serum or other serum substitutes are needed in the culturing system. As HIPP-T009 contains no exogenous cytokines or activators, corresponding cytokines or activators should be added if necessary.
Features
Xeno-free, contains no growth factors, synthetic activators, or undefined components
Universality and flexibility: Applicable for the culture of T-cell, NK cell, CAR-T, CIK, CAR-NK, hematopoietic stem cells and other types of cell lines (NK-92, NK-92MI, K562, Jurkat, etc.)
High performance in cell expansion and high-density culture under completely serum-free condition
Advantages
The 1st approved Chinese culture medium used in cell therapy clinical trials;
No need to add serum, plasma, or serum substitutes, hence it minimizes batch-to-batch variation in the culture process and simplifies the declaration process for IND/NDA applications;
Manufactured under the cGMP guidelines and ISO13485 quality system, meet regulatory requirements in different countries;
Innovative “2 domestic+1 imported” raw material supplier modal ensures a stable supply chain to face the fluctuations and uncertainty in the raw material market;
The comprehensive set of DMR documents for audit.
Audited Supplier
Pharma Sources Insight January 2025
